Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment, and Hepatocellular Carcinoma Treatment and Prognosis.
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma
Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study
Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer
CiTSA: a comprehensive platform provides experimentally supported signatures of cancer immunotherapy and analysis tools based on bulk and scRNA-seq data
Additional file 1 of Comparable clinical outcomes of culture-negative and culture-positive periprosthetic joint infections: a systematic review and meta-analysis
Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project
Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma
Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer
Unclassified renal cell carcinoma: a clinicopathological, comparative genomic hybridization, and whole-genome exon sequencing study.
PubMed 2014cited by 6position: last